High Plasma Renin and Aldosterone Levels Are Associated With a Unique Phenotype in Primary Hypertension

Jung Sun Cho1,2, Ji-Hoon Jung3, Woojin Kwon4

  • 1Division of Cardiology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

PubMed

Insights

Patients with primary hypertension and high renin and aldosterone levels are often younger and have higher pulse rates. This phenotype is also linked to microalbuminuria and elevated uric acid, suggesting a need for personalized treatment strategies.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiovascular Medicine

Background:

  • Primary hypertension is a heterogeneous condition.
  • Subgrouping based on hormonal profiles, like renin and aldosterone, is crucial for understanding disease mechanisms.
  • Low-renin hypertension is a recognized phenotype, but high-renin and high-aldosterone phenotypes require further investigation.

Purpose of the Study:

  • To explore the clinical phenotype of untreated primary hypertension patients with high renin and aldosterone levels.
  • To identify predictors and associated conditions within this specific hypertensive subgroup.
  • To emphasize the clinical utility of stratifying hypertensive phenotypes for personalized medicine.

Main Methods:

  • A cohort of 747 untreated primary hypertension patients was analyzed.
  • Patients were stratified into four groups based on plasma renin activity and plasma aldosterone concentration thresholds.
  • Statistical analysis, including multinomial logistic regression, was used to identify predictors.

Main Results:

  • High renin and aldosterone levels were independently predicted by younger age, higher pulse rates, and greater nighttime systolic blood pressure.
  • Microalbuminuria was significantly more prevalent in the high renin and aldosterone group (25.5%).
  • Elevated uric acid levels were also more common in this phenotype (5.5±1.4 mg/dL).

Conclusions:

  • The high renin and aldosterone phenotype in primary hypertension is associated with specific clinical characteristics.
  • These findings underscore the importance of identifying distinct hypertensive phenotypes.
  • Personalized treatment approaches are essential for managing primary hypertension subgroups effectively.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
787
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K